Radius health, inc. (RDUS)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss

-132,993

-221,337

-254,237

-182,804

-101,526

-62,479

-60,690

-69,128

-42,476

-14,630

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,308

2,867

1,951

586

176

77

27

44

40

70

Gain on fixed asset disposal

-

-

-

-

-

-

-

-

-

100

Amortization of discount on marketable securities, net

394

390

264

-791

-1,714

-429

-27

-101

-21

-303

Research and development expense settled in stock

-

-

-

-

-

2,717

13,118

15,067

10,296

-

Change in fair value of other current assets, warrant liability and other liability

-

-

-

-

-

505

-9,087

2,069

264

-

Amortization of debt discount and debt issuance costs

15,785

13,800

4,816

0

183

295

387

449

165

-

Impairment loss on operating lease right of use assets

339

-

-

-

-

-

-

-

-

-

Stock-based compensation

23,615

28,701

35,003

26,058

14,734

7,070

1,508

1,795

304

134

Loss on disposals of property and equipment

-201

0

0

-

-

-

-

-

-

-

Loss on retirement of note payable

-

-

-

-

1,572

57

-

-

-

-

Milestone payment settled with stock

-

-

-

-

-

-

-

-

1,410

-

Changes in operating assets and liabilities:
Inventory

-887

1,844

4,366

0

0

-

-

-

-

-

Accounts receivable, net

6,531

12,317

4,441

0

0

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

1,639

-1,721

-4,623

6,463

133

Prepaid expenses

-1,711

8,667

3,689

342

1,157

-

-

-

-

-

Other current assets

-356

-989

1,362

-4,996

3,757

-

-

-

-

-

Operating lease right of use assets

2,034

-

-

-

-

-

-

-

-

-

Other long-term assets

-30

-255

248

291

108

105

-

-35

-25

27

Accounts payable

1,804

311

-2,213

-100

3,936

1,991

-250

237

-301

-94

Accrued expenses and other current liabilities

10,827

-7,000

22,563

11,349

-2,870

2,737

8,222

1,550

819

1,491

Lease liability, operating leases

2,298

-

-

-

-

-

-

-

-

-

Other non-current liabilities

-95

-94

-190

0

0

-

-

-

-

-

Net cash used in operating activities

-82,414

-204,726

-206,677

-139,757

-87,103

-48,345

-45,017

-43,158

-35,896

-12,986

CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:
Purchases of property and equipment

0

185

2,341

2,936

1,231

857

2

40

176

14

Collaborative Arrangement, Milestone Payments

0

0

8,712

0

0

-

-

-

-

-

Purchases of marketable securities

119,502

499

429,296

260,547

579,088

97,678

17,070

18,989

32,479

24,120

Proceeds from sale of equipment

-

-

-

-

-

-

-

-

-

149

Sales and maturities of marketable securities

206,779

135,000

191,363

499,603

340,497

20,470

21,043

46,464

8,855

39,655

Net cash provided by (used in) investing activities

87,277

134,316

-248,986

236,120

-239,822

-78,065

3,971

27,435

-23,800

15,670

CASH FLOWS PROVIDED BY FINANCING ACTIVITIES:
Proceeds from exercise of stock options and warrant exercises

3,869

9,106

17,478

2,573

2,337

170

13

279

204

-

Net proceeds from the issuance of preferred stock, net

-

-

-

-

-

27,368

42,870

-

62,116

-

Proceeds from issuance of convertible notes

0

0

305,000

0

0

24,555

-

12,500

12,500

-

Proceeds from issuance of common stock, net

-

-

-

-

482,250

103,804

-

-

-

2

Discount on note payable

-

-

-

-

-

-

-

-

366

-

Deferred financing costs

0

0

9,360

0

0

116

-

31

56

-

Payments on note payable

-

-

-

-

25,000

13,156

8,187

3,500

156

-

Fee for early prepayment of note payable

-

-

-

-

1,502

0

-

-

-

-

Proceeds from issuance of shares under employee stock purchase plan

1,840

2,566

2,550

0

0

-

-

-

-

-

Net cash provided by financing activities

5,709

11,672

315,668

2,573

458,085

142,625

34,696

9,248

74,242

2

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

10,572

-58,738

-139,995

98,936

131,160

16,215

-6,350

-6,475

14,546

2,686

SUPPLEMENTAL DISCLOSURES:
Cash paid for interest

9,150

9,582

0

0

1,490

1,971

1,796

1,801

358

-

Accretion of preferred stock issuance costs

-

-

-

-

-

-

-

-

-

173

NON-CASH FINANCING ACTIVITIES:
Accretion of dividends on preferred stock

-

-

-

-

-

9,000

17,471

-13,992

-10,933

10,651

Reclassification of preferred stock to common stock

-

-

-

-

-

298,063

-

-

-

-

Accretion of preferred stock investor rights/obligations

-

-

-

-

-

-

-

-

-

1,318

Property and equipment purchases in accrued expense

0

309

352

675

0

0

-

-

-

-

Right of use assets obtained in exchange for operating lease liability

9,077

-

-

-

-

-

-

-

-

-

Fair value of preferred stock issued in the recapitalization

-

-

-

-

-

-

-

-

85,879

-

Fair value of series A-6 convertible preferred stock issued as settlement of liability

-

-

-

-

-

10,109

23,168

-

-

-

Fair value of warrants issued

-

-

-

-

-

1,552

1,356

379

463

-